News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab
Photo from Polyak Lab/Twitter
Sep 11, 2023, 00:27

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab

Polyak Lab recently shared on X/Twitter:

“Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for TNBC is out in Molecular Cancer Therapeutics today. Congrats to all the coauthors! And of course a lot more to be explored in the future.”

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. - Polyak Lab

For the article click here.
Source: Polyak Lab/Twitter

anti-PD-L1 BRD4 inhibitor cancer Molecular Cancer Therapeutics OncoDaily Oncology Paclitaxel Polyak Lab TNBC
Special Coverage
Science
Jan 12, 2025, 10:52
Myeloma Paper of the Day, January 12th, suggested by Robert Orlowski
Blog
Jan 12, 2025, 09:13
Shaban Juma: The importance of HPV vaccination and early screening for pre-malignant lesions
Blog
Jan 12, 2025, 09:05
Examining the prevalence and risk factors of metabolic syndrome among adult survivors of childhood cancer.
Blog
Jan 12, 2025, 08:51
Eribulin + HP as first-line treatment of locally advanced/metastatic HER2+ breast cancer
Blog
Jan 12, 2025, 08:44
Isabel Preeshagul: Addressing barriers to clinical trial accrual in patients with lung cancer
Blog
Jan 12, 2025, 08:00
Implementation of AI for cancer detection in population-based mammography screening
Blog
Jan 12, 2025, 07:53
Ponsegromab as a novel, targeted therapy to address unmet needs of patients with cancer and cachexia
Blog
Jan 12, 2025, 07:18
Northern Ireland is now among the first places in the world to estimate how many people are living secondary breast cancer
Insight
Jan 12, 2025, 07:12
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer
Insight
Jan 12, 2025, 07:07
Elvina Almuradova: ctDNA/MRD testing shows promise in guiding colon cancer treatment
Blog
Jan 12, 2025, 07:02
A new guideline update on the treatment of pleural mesothelioma - ASCO
Insight
Jan 12, 2025, 06:53
Drew Moghanaki: More fuel to the fire on debates about "more immunotherapy" after surgery